HIV research has led to advances for multiple diseases
Dr. Larry Corey emphasized that “Thanks to broad U.S. investment, HIV research has opened the door to breakthroughs and treatments for diseases far beyond HIV/AIDS.”
How Seattle scientists are helping research a path to HIV cure
Drs. Lillian Cohn and Dan Reeves shared insights from two groundbreaking HIV studies published on World AIDS Day. Cohn noted: “We’re in a very paradoxical moment in the world. The science is at the best point it’s ever been.”
HIV’s most promising breakthrough has taken a hit
Dr. Jim Kublin explained that approaches using the mRNA platform for developing an HIV vaccine “are not at all dead in the water” despite mild side effects observed in a recent study.
Addressing the infectious disease challenges in immunocompromised patients
Dr. Josh Hill discussed how “immune compromised patients are those that we need to study the most carefully, because they are sometimes at the most risk for the infection or worse outcomes from infectious diseases."
Seattle scientists make progress on cure for genital herpes
Dr. Keith Jerome explained how dormant herpes infections can emerge “from this hiding place in the nerves... reactivate themselves and come back out, transmit to a new person or they can cause visible or sometimes painful lesions.”
Seattle scientists make progress on cure for genital herpes
Dr. Keith Jerome explained how dormant herpes infections can emerge “from this hiding place in the nerves... reactivate themselves and come back out, transmit to a new person or they can cause visible or sometimes painful lesions.”
Bird flu virus isolated from hospitalized Canadian teen shows signs of human adaptation
Dr. Jesse Bloom commented on viral mutations found in a case of H5N1. He said, “It’s caught the attention of a lot of flu virologists, including myself, because some of the sequence has evidence of some of the types of mutations we worry about.”
COVID vaccine update: CDC now recommends second dose for older adults, immunocompromised
Dr. Larry Corey talked about the evolution of COVID noting, “The effects that the early vaccination had have long worn off, and the virus has escaped from them. The hope is double boosting will transfer your immunity.”
Meet the 2024 STAT Wunderkinds
STAT included Miguel Paredes in the Bedford Lab and Yapeng Su in the Greenberg Lab in its Wunkerkinds awards to 27 of the “most impressive doctors and researchers on the cusp of launching their careers.”
A viral gene drive could offer a new approach to fighting herpes
Drs. Keith Jerome and Marius Walter discussed their Nature Communications study on gene editing for herpes. Jerome explained his hope for a herpes cure: “You don’t ever have to worry about this virus again.”
What does it mean to be immunocompromised?
Fred Hutch patient Kaley Karaffa and Dr. Josh Hill explained how being immunocompromised impacts daily life. Karaffa said, “I had to become cautious about who I saw, the activities I was involved in and even the kind of food I ate.”
Was Missouri’s bird flu case a one-off or something more? Quest for answers faces testing delay
Dr. Jesse Bloom explained how virus mutations could change the accuracy of serology tests for infections: "This type of mutation could make you want to then redo the assays with a virus that contained that mutation.”
These four common infections can cause cancer
Drs. Denise Galloway and Nina Salama discussed how HPV and H. Pylori can cause cancer. Galloway said, “If you vaccinate someone who’s young, the risk goes down to zero.”
FDA authorizes updated COVID vaccines. Who should get the shot and when, according to experts
Dr. Larry Corey recommended everyone eligible for the COVID vaccine update get one. He said, “When we look at people who are currently hospitalized, they haven’t been boosted for a long time.”
Despite Gilead’s Promising HIV Prevention Drug, A Vaccine Is Still The ‘Holy Grail’
Dr. Jim Kublin characterized an effective HIV vaccine as the “holy grail of HIV prevention.”
AIDS crisis from 1980s to today: How Seattle responded with hope, healing
Ro Yoon and Dr. Larry Corey shared perspectives on HIV research, activism and public fatigue. Yoon emphasized the importance of keeping HIV “relevant to an audience that might not be aware of the long, hard history of activism.”
Herpes cure on the horizon
Dr. Keith Jerome discussed his team’s progress in developing a gene therapy for herpes simplex virus. He said, “There’s not a cure yet that everybody can go out and get, but we’re getting closer to a cure.”
Seattle virologists find promising new results for potential herpes cure
Dr. Keith Jerome described how his team’s herpes cure research could help people who want to be cured of their infection: “What we want to do is offer a tool that says if this really matters to you, we can help make your life better.”
There’s bird flu RNA in grocery store milk. How sequncing it might help fight avian influenza
Dr. Pavitra Roychoudhury described how researchers sequenced a bird flu genome from store-bought milk, noting that “this is, to our knowledge, the first time it’s been done in commercially available milk, to obtain the full genome.”
Move over, wastewater. Store-bought milk could be another way to track the bird flu outbreak in cows
Dr. Trevor Bedford noted that “separate from the sequencing for evolution [of the virus], which I think is very important, just even understanding prevalence through space and time... would be really helpful and important.”
The new horizon of HIV vaccines
Louis Shackleford emphasized that “the prospect of having a vaccine that can last for years and give us sustained protection from HIV would be an amazing boon for communities such as the Black community who disproportionately are suffering from HIV.”
A new type of bacteria was found in 50% of colon cancers. Many were aggressive cases.
Dr. Susan Bullman explained a new Nature study she co-authored with Dr. Chris Johnston and how a specific subtype of bacterium helps tumor cells hide from therapies: “It acts like a cloak.” Many medical and health news outlets also covered the study.
After decades of failures, researchers have renewed hopes for an effective HIV vaccine
Dr. Julie McElrath declared in a plenary talk at CROI that “An HIV vaccine could end HIV. So I say, ‘Let’s just get on with it.’”
Dr. Jim Boonyaratanakornkit discusses respiratory illnesses
Dr. Jim Boonyaratanakornkit encouraged people to get vaccinated for COVID, flu and RSV.
Can these drugs stop a COVID infection in its tracks? Seattle researchers are on the forefront of new treatments
Dr. Liz Duke explained a study of antivirals to prevent COVID.
There’s still no HIV vaccine. The science behind coronavirus vaccines may help
Dr. Larry Corey compared the challenge of developing effective HIV vaccines with raising children.
New area eligibility for high-demand COVID-19 prevention drug
Dr. Catherine Liu and Rebecca Relyea, a patient, discussed a monoclonal antibody drug that prevents COVID in people who are immunocompromised.
COVID cases are up. Most mandates ended months ago. So where does WA stand?
Drs. Josh Schiffer and Trevor Bedford shared COVID-19 insights.
What’s next? How the COVID-19 pandemic is likely to look over the next few months
Dr. Rachel Bender Ignacio advocated for expanded access to COVID antivirals.
COVID hasn’t given up all its secrets. Here are 6 mysteries experts hope to unravel
A STAT special report noted Dr. Trevor Bedford’s COVID predictions.
As COVID rates rise in Europe and Asia, how worried should Americans be about another wave?
Dr. Josh Schiffer reflected on the evolving nature of the pandemic.
As virus data mounts, the J&J vaccine holds its own
Dr. Larry Corey commented on longer-term immune data on the J&J COVID vaccine.
What health experts say about the ‘natural experiment’ of ditching mask mandates in WA
Dr. Josh Schiffer recommended a flexible approach to SARS-CoV-2 measures going forward.
As COVID-19 cases fall, experts are optimistic, but for how long?
Dr. Elizabeth Halloran shared her thoughts on COVID-19 outlook in the U.S.
Project underway at Fred Hutch to bring more diversity to clinical trials
Drs. Michele Andrasik and Stephaun Wallace discussed diversity in vaccine trials.
COVID predictions? These experts are done with them
Drs. Josh Schiffer, Pavitra Roychoudhury and Trevor Bedford shared omicron insights.
COVID antiviral pills work against omicron– when people can get them
Dr. Elizabeth Duke explained how COVID antivirals work.
After omicron, some scientists foresee a period of quiet
Dr. Trevor Bedford shared predictions about omicron.
Could Genomic Surveillance Prevent The Next Pandemic?
Dr. Trevor Bedford discussed the Seattle Flu Study and tracking viruses in a Bloomberg mini-documentary on genomic surveillance.
Halting progress and happy progress: How mRNA vaccines were made
Drs. Elizabeth Halloran and Larry Corey described decades of scientific effort that led to COVID vaccines.
Omicron is spreading at lightning speed. Scientists are trying to figure out why
Dr. Josh Schiffer compared omicron to previous variants.
Healthy, boosted people unlikely to develop severe omicron infections, but jury’s out on older, at-risk populations
Dr. Larry Corey highlighted the strain on hospital systems.
How contagious is omicron? What does that mean for you?
Dr. Josh Schiffer characterized recent COVID variants.
A computational biologist weighs in on omicron, the future of vaccines and the CDC’s variant forecast
Dr. Trevor Bedford shared insights in a Q&A, including updating COVID vaccines to circulating variants.
Gauteng’s Omicron Wave Is Already Peaking. Why?
In a Q&A, Dr. Trevor Bedford discussed the rapid rise of omicron and challenges in detecting cases.
Omicron surge predicted to peak higher than delta wave in King County: ‘It’s here and it’s moving fast'
Dr. Trevor Bedford joined a press briefing on omicron.
How the little-known B and T cells can protect against COVID variants
Dr. Jennifer Lund explained the immune response to COVID.
A Guide to Mixed-Vaccination-Status Holidays
Dr. Larry Corey talked about the complexity of COVID, quarantines and young children.
Preparing for the Omicron Wave (with Trevor Bedford)
Dr. Trevor Bedford and Andy Slavitt discussed omicron.
Scientists in Washington researching COVID-19 Omicron variant to help protect public
Dr. Josh Schiffer described his concerns about omicron infections.
How did omicron mutate, and how could it evade antibodies? Fred Hutch scientist Trevor Bedford answers our questions
In an omicron-focused Q&A, Dr. Trevor Bedford mentioned how to prevent future variants.
Why Didn’t the U.S. Detect Omicron Cases Sooner?
Dr. Trevor Bedford commented on genomic surveillance of SARS-CoV-2.
Dr. Larry Corey on the Omicron variant of COVID
Dr. Larry Corey answered viewer questions about omicron, including vaccine efficacy.
Omicron’s Best- and Worst-Case Scenarios
Dr. Elizabeth Halloran talked about implications of the latest COVID-19 variant.
The mystery of where omicron came from — and why it matters
Dr. Trevor Bedford discussed omicron’s evolutionary path.
Mysteries of omicron variant could take weeks to untangle
Dr. Trevor Bedford discussed early reports of spread of the omicron variant.
COVID-19 experts answer questions about Omicron -- and where the variant may have come from
Drs. Larry Corey and Pavitra Roycoudhury discussed the Omicron variant.
The Omicron variant might have originated in someone with a suppressed immune system
Dr. Trevor Bedford explained how omicron differs from other gradually evolving strains of SARS-CoV-2.
U.S. tracking of virus variants has improved after a slow start
Dr. Trevor Bedford spoke on sequencing of variants.
How bad will omicron be? Scientists won’t really know for months
Dr. Josh Schiffer noted that larger data sets are needed to understand omicron.
A different type of COVID vaccine is about to roll around the world
Dr. Julie McElrath provided context about subunit protein vaccines, like those made by Novavax and Sanofi.
Treatments will change the pandemic, but they can’t end it alone
Dr. Larry Corey reflected on how COVID will change our response to respiratory illnesses.
The pandemic’s next turn hinges on three unknowns
Dr. Elizabeth Halloran commented on COVID-19 immunity in the U.S.
COVID-19 Virus to Keep Mutating, but at Slower Rate, Expert Predicts
Dr. Trevor Bedford’s recent Twitter thread on how SARS-CoV-2 might continue to evolve was featured.
COVID vaccines were rolled out 10 months ago in Washington state. Where do we stand now?
Dr. Larry Corey commented on measures enacted to fight COVID-19.
FDA clears first coronavirus vaccine for 5- to 11-year-olds
Dr. Larry Corey reflected on the FDA’s approval of Pfizer’s COVID vaccine in children.
Local doctors say children 5-11 years old could get vaccine by Thanksgiving
Dr. Larry Corey discussed when 5-11 year olds may receive the vaccine.
Can New Variants of the Coronavirus Keep Emerging?
Dr. Josh Schiffer discussed implications for immunity against COVID-19 as SARS-CoV-2 continues to mutate.
What to know about your risk of a serious or fatal breakthrough COVID infection
Dr. Rachel Bender Ignacio provided perspective on breakthrough COVID infections.
Why COVID boosters weren’t tweaked to better match variants
Dr. Trevor Bedford advocated for updating COVID vaccines against the Delta variant.
Yes, We’re Still Talking about Covid Vaccine Myths
Dr. Larry Corey underscored the safety of COVID vaccines.
Is There Another Reason Biden Likes Boosters?
Dr. Larry Corey commented on COVID vaccine boosters.
Merck COVID drug studied at Fred Hutch
Dr. Rachel Bender Ingacio characterized clinical trial results for molnupiravir.
Merck Says It Has the First Antiviral Pill Found to Be Effective Against Covid
Dr. Elizabeth Duke explained the potential of molnupiravir.
Fred Hutch’s Trevor Bedford receives ‘genius grant’ for work on COVID-19 and other viruses
Dr. Trevor Bedford commented on being named a 2021 MacArthur Fellow.
Trevor Bedford: Two astounding awards for virologist who raised early COVID alarms
Dr. Trevor Bedford reflected on receiving recognition for his research on viral evolution.
A daily pill to treat COVID could be just months away, scientists say
Dr. Elizabeth Duke spoke about the promise of an oral antiviral to treat and even prevent COVID.
These three Seattle scientists study the coronavirus. Now they’re getting millions to chase their ‘wildest scientific ideas’
Drs. Erick Matsen and Trevor Bedford were named Howard Hughes Medical Institute investigators.
Remdesivir Averts Hospitalization in Study of High-Risk Patients
Dr. Josh Hill commented on a study of Remdesivir in high-risk patients:
Winter is coming, again: What to expect from Covid-19 as the season looms
Dr. Trevor Bedford predicted near-term and future spread of SARS-CoV-2.
COVID vaccine immunity is waning — how much does that matter?
Dr. Julie McElrath noted that COVID vaccines continue to prevent hospitalization and death.
Long-haul COVID-19 can last months. But here’s why experts are optimistic about recovery.
Dr. Julie McElrath and collaborators from the Allen Institute discussed research in immune response and understanding long COVID.
Analysis: U.S. hopes COVID vaccine boosters will decrease not just deaths, but virus spread
Dr. Larry Corey noted that vaccine boosters may prevent transmission.
Covid-19 Virus Variants Mu and Lambda Unlikely to Supplant Delta
Dr. Trevor Bedford characterized the landscape of COVID variants.
United States boosts tracking of coronavirus strains as Mu variant draws scrutiny
Dr. Trevor Bedford commented on the volume of COVID genomes now available in the U.S.
Johnson & Johnson’s HIV vaccine fails first efficacy trial
Dr. Larry Corey characterized results from an HIV vaccine study he helped lead.
Many patients with cancer lack adequate immunity to measles, mumps
Dr. Steve Pergam and Elizabeth Krantz discussed their study on cancer patients and immunity to measles and mumps.
New Evidence Points To Antibodies As A Reliable Indicator Of Vaccine Protection
Dr. Holly Janes spoke with NPR.
Q&A: Seattle COVID-19 vaccine expert answers questions about booster shots
Dr. Larry Corey discussed COVID vaccine boosters.
As Delta Surges, Covid-19 Breakthrough Cases Remain Uncommon
Dr. Larry Corey discussed breakthrough cases of COVID.
Why a fast-spreading coronavirus and a half-vaccinated public can be a recipe for disaster
Dr. Josh Schiffer discussed the rise of variants.
Patients With Cancer May Have an Increased Risk for Measles and Mumps
Dr. Steve Pergam and Elizabeth Krantz discussed their study on measles and mumps immunity in cancer patients.
Many People With Cancer Lack Protection Against Measles and Mumps
Dr. Steven Pergam and biostatistician Elizabeth Krantz discussed their research on cancer patients and immunity to mumps and measles.
Study showing antibody levels protecting against COVID-19 could speed creation of new vaccines, boosters
Dr. Peter Gilbert explained a study identifying correlates of protection for the Moderna virus.
Antibody levels predictive of Moderna's vaccine efficacy -study
Dr. Peter Gilbert explained a study identifying correlates of protection for the Moderna virus.
Scientists may have found a marker of how effective COVID-19 vaccines are
Dr. Peter Gilbert explained a new study identifying correlates of protection for the Moderna vaccine.
Will COVID vaccine booster shots be needed? It's likely, experts say, but the immunocompromised should be prioritized.
Dr. Larry Corey commented on COVID vaccines in immunocompromised people.
‘Goldilocks virus’: Delta vanquishes all variant rivals as scientists race to understand its tricks
Dr. Trevor Bedford commented on the delta variant with The Washington Post.
There Are Few Good COVID Antivirals, but That Could Be Changing
Dr. Rachel Bender Ignacio explained how small molecule antivirals still work when viruses develop resistance.
Can we stretch existing Covid vaccines to inoculate more people? Experts are divided
Dr. Larry Corey expressed concern about using partial doses of COVID vaccines to increase global access to the vaccines without clinical data.
Covid’s Lambda variant: worth watching, but no cause for alarm
Dr. Trevor Bedford described the newly emerged Lambda variant.
12 lessons COVID-19 taught us about developing vaccines during a pandemic
Dr. Larry Corey shared his reflections on the COVID vaccine program.
Vaccine Hesitancy or Systemic Racism?
Dr. Stephaun Wallace and co-authors wrote an op-ed on the misperceptions around vaccine hesitancy.
Study testing Moderna vaccine in transmission prevention to include young adults
Dr. Larry Corey commented on a study that is testing whether the Moderna COVID-19 vaccine works to prevent infection and transmission of the virus.
Two reasons why doctors say anyone who's had COVID still needs to get poked
Dr. Stephaun Wallace explained why people who previously had COVID-19 still need to get vaccinated.
One year or five? Doctors and drug companies increasingly disagree about when we'll need COVID-19 booster shots
Dr. Larry Corey gave context around COVID vaccine efficacy and durability. He said, “If the duration of protection is such that you can still get a mild cold, but you don't end up in the hospital, the vaccine will still be a success.”
Stephaun Wallace on Seattle Gay News' inaugural podcast
In Seattle Gay News’ inaugural podcast, Dr. Stephaun Wallace discussed COVID and HIV vaccine research and engaging communities in science. He said, “One of the things I really appreciate about science is that you’re always learning something.”
A pandemic upside: The flu virus became less diverse, simplifying the task of making flu shots
Dr. Trevor Bedford reacted to speculation that a clade of the influenza virus may have gone extinct during the pandemic. He said, “I think it has a decent chance that it’s gone. But the world’s a big place.”
Who really needs coronavirus herd immunity? People with weakened immune systems
Drs. Josh Hill and Steve Pergam discussed COVID immunity among immunocompromised people. Dr. Hill pointed out that for those with weakened immune systems, “Antibody tests are just the tip of the iceberg of what the immune system is doing.”
As Covid dissipates in the U.S., cold and flu viruses may return with a vengeance
Dr. Trevor Bedford commented on the rise in circulating respiratory viruses as COVID restrictions decrease.
Finding how much protection is enough when it comes to COVID-19 vaccines
Dr. Peter Gilbert told KIRO 7 about how he is working to find the “correlate of protection."
A Kent church is closing the vaccine equity gap, sometimes to a round of applause
Dr. Michele Andrasik commented on building vaccine confidence.
Masks and social distancing may still be needed for people with compromised immunity
Dr. Josh Hill emphasized how broad COVID vaccination can “protect our vulnerable patient populations within the community who either can’t get vaccinated for some reason, or who may not have as good of a vaccine response.”
The race to avoid a possible "monster" COVID variant
Dr. Josh Schiffer stressed rapid vaccination.
A vaccine without needles? It’s on the way
Dr. Jim Kublin spoke with CNN about next-gen vaccine delivery technologies.
College Students Are Helping Answer Key Vaccine Questions, but Finding Enough of Them Is Tough
Dr. Holly Janes explained the PreventCOVIDU study of COVID vaccines and transmission.
Meet the Seattle doctor who Dr. Fauci trusted to help develop COVID-19 vaccines
Drs. Tony Fauci and Larry Corey reflected on their collaboration on HIV and COVID vaccines.
New Blood Tests Should Show How Long A COVID-19 Vaccine Will Protect You
Dr. Peter Gilbert discussed studies of what immune responses protect against COVID-19.
Scientists Are Working On Booster Shots In Case COVID-19 Vaccines Lose Their Effect
Dr. Peter Gilbert discussed how to test vaccine protection against SARS-CoV-2 variants.
What the Recent HIV Vaccine Research Findings Really Mean
Dr. Larry Corey commented on the challenge of creating an effective HIV vaccine.
Behind the mask: Public health innovator Dr. Stephaun Wallace
Dr. Stephaun Wallace reflected on his career in public health.
A vaccine study in college students will help determine when it’s safe to take masks off
Dr. Larry Corey explained one of the questions the Prevent COVID U study is designed to answer:
You got vaccinated. Now what? 7 things to know for your post-COVID vaccine behavior
Dr. Josh Schiffer spoke with Geekwire and gave his input on SARS-CoV-2 variants.
Meet an epidemiologist fighting to make vaccines work for communities of color
Bill Gates featured Dr. Stephaun Wallace’s work in his personal blog.
Researchers pursuing novel treatments for herpes infections and diabetes win STAT Madness
Drs. Keith Jerome and Martine Aubert won the annual STAT Madness contest for biomedical research.
NCCN Guidelines Urge Patients With Cancer to Get a COVID-19 Vaccine, Whichever is Available
In a Q&A, Dr. Steve Pergam discussed national guidelines on COVID vaccines in cancer patients.
Luck is essential for any successful coronavirus variant, study shows
Dr. Josh Schiffer explained his team’s latest analysis of how super-spreader events allow variants to become predominant and create new variants.
Unlocking the COVID code
Dr. Trevor Bedford commented on advances in the viral genomics field.
Do COVID-19 vaccines stop transmission? Top scientists are now recruiting thousands of college students to find out
Dr. Larry Corey discussed a new study to find out if COVID vaccines prevent transmission.
Disappointment and Hope From Two HIV Prevention Trials
Dr. Larry Corey characterized results from the Antibody Mediated Prevention studies, coordinated through the HIV Vaccine Trials Network, as “important proof of concept” in using antibody infusions to prevent HIV.
‘On your toes’ approach to managing infection risk needed as CAR T-cell therapy evolves
In a Q&A, Dr. Josh Hill discussed treating infections in people receiving CAR T-cell therapy.
COVID-19 precautions shut down flu this season, but what will next winter bring?
Dr. Steve Pergam reflected on how public health measures helped reduce spread of other respiratory viruses.
Did Washington Get Its Vaccine Line Right?
Dr. Laura Matrajt discussed her mathematical models of COVID-19 vaccine distribution.
‘Then the world caved in’: 11 experts describe the day they realized Covid-19 was here to stay
STAT opinion included reflections on the pandemic from a variety of experts when they realized COVID-19 was here to stay.
We may never reach herd immunity on coronavirus — but it probably doesn’t matter
Drs. Larry Corey, Josh Schiffer and Trevor Bedford spoke with The Seattle Times about herd immunity.
Worried About Coronavirus Variants? Here's What You Need To Know
Dr. Trevor Bedford commented on which variants we should watch and how concerned people should be..
The Coronavirus Is Plotting a Comeback. Here’s Our Chance to Stop It for Good.
Dr. Josh Schiffer provided context on how the new coronavirus variants makes modeling difficult.
Washington high schools return to play knowing the COVID-19 risks, but hopeful about safety protocols
Dr. Josh Hill cautioned that high school sports may be disrupted by COVID-19.
People Who Have Had Covid Should Get Single Vaccine Dose, Studies Suggest
Dr. Andy McGuire discussed findings from the Seattle COVID Cohort Study showing a “massive, massive boost” from the vaccine administered to people who had had COVID.
People of color are underrepresented in US vaccine trials, study finds
Drs. Steve Pergam and Michele Andrasik stressed the need for more diversity and inclusion in vaccine clinical trials.
C.D.C. Announces $200 Million ‘Down Payment’ to Track Virus Variants
Dr. Trevor Bedford commented on new funding to support genomic surveillance and data collection related to COVID.
Drugmakers Look for New Ways to Test Covid-19 Vaccines
Dr. Peter Gilbert described measuring immune responses to vaccines as a way of testing their efficacy.
The coronavirus is going to stick around forever. Get ready for the new normal.
Dr. Larry Corey gave his thoughts to Business Insider about SARS-CoV-2 becoming endemic.
Covid masks save lives. The CDC says double-masking may save more.
In an op-ed, Dr. Josh Schiffer advocated for increased masking to limit the COVID-19 pandemic.
South Africa suspends Oxford-AstraZeneca vaccine rollout after researchers report ‘minimal’ protection against coronavirus variant
Dr. Larry Corey gave his insight on the pause in rolling out the AstraZeneca vaccine in South Africa.
With COVID-19 vaccine in short supply, scramble is on for second shots
Dr. Steve Pergam explained why people should get their COVID-19 vaccines from the same provider.
Mutated virus may reinfect people already stricken once with covid-19, sparking debate and concerns
Dr. Larry Corey was quoted in The Washington Post on the potential for reinfection from some variants.
If I have cancer, dementia or MS, should I get the Covid vaccine?
Dr. Catherine Liu commented on emerging recommendations for cancer patients receiving COVID-19 vaccines.
For the first time, researchers say infusions of antibodies can prevent HIV infection
Dr. Larry Corey reflected on results from the Antibody Mediated Prevention study.
Why vaccines alone will not end the pandemic
Dr. Trevor Bedford weighed in on modeling that predicted lifting public health guidelines in February could cause 29 million additional coronavirus cases by July.
New strains of COVID swiftly moving through the US need careful watch, scientists say
Dr. Larry Corey stressed that to slow the spread of variants of concern, as we expand access to COVID-19 vaccines, “We have to do everything we can to decrease the risk of transmission and acquisition.”
Are new coronavirus variants already in Washington state? With limited surveillance it’s hard to know
Drs. Pavitra Roychoudhury, Jesse Bloom and Trevor Bedford commented on efforts to track SARS-CoV-2 variants.
C.D.C. Warns the New Virus Variant Could Fuel Huge Spikes in Covid-19 Cases
Dr. Trevor Bedford estimated that with a more transmissible variant, “It makes the same situations that generate spread now — people living in the same household, these sorts of non-ventilated indoor contacts — to be more likely to spread.”
New stem cell study provides clues for treatments that could eliminate HIV in infected patients
Dr. Fabian Cardozo-Ojeda described the collaboration that went into utilizing models to potentially cure HIV through stem cell transplants.
Math Can Help In Deciding How To Distribute The Vaccine
Dr. Laura Matrajt discussed her computer model that showed the benefit of administering one-dose vaccines to end the pandemic.
Fred Hutch seeks volunteers with COVID-19 to join tests of therapies
Research nurse Corrie Moreau described her motivation for being involved with COVID-19 therapy studies.
Vaginal fluid transplants hold promise but raise safety concerns
Dr. David Fredricks, a microbiome researcher, provided expert commentary on vaginal microbiota transplantation.
HIV vaccine shows signs of cross-subtype protection
FierceBiotech featured a Fred Hutch study suggesting cross-subtype immune response against HIV in South Africa.
Geek of the Week: Fred Hutch’s Steve Pergam caught a ’bug’ for infectious diseases and research
Fred Hutch researcher Dr. Steve Pergam is featured as GeekWire’s ‘Geek of the Week’. Dr. Pergam is an associate member of the Vaccine and Infectious Disease Division at Fred Hutch.
This ring can help stop the spread of HIV in women
Quotes Elizabeth Brown from the vaccine and infectious disease division on her study on women using vaginal rings to prevent HIV infection. Brown's research follows the larger ASPIRE study that tested the monthly ring